MANHATTAN SCIENTIFICS INC: going-concern / distress — Manhattan Scientifics files Chapter 7 bankruptcy; assets to be liquidated

MANHATTAN SCIENTIFICS INC

Filed voluntary Chapter 7 petition on April 4, 2025 in Southern District of Florida, case no. 25-13705-MAM.
Interim Chapter 7 Trustee Nicole Testa Mehdipour appointed to oversee liquidation.
Company expects stockholders may experience significant or complete loss on their investment.
Trading in common stock is highly speculative during bankruptcy proceedings.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

MANHATTAN SCIENTIFICS INC entered chapter 7 in United States Bankruptcy Court for the Southern District of Florida (petition 2025-04-04).

Proceeding: chapter 7
Court: United States Bankruptcy Court for the Southern District of Florida
Petition: 2025-04-04

Exact text from the filing

On April 4, 2025, Manhattan Scientifics, Inc. (the “Company”) announced that it commenced bankruptcy proceedings (the “Chapter 7 Case”) by filing a voluntary petition for relief under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §101 et seq. (the “Bankruptcy Code”). The Chapter 7 Case was filed in the United States Bankruptcy Court for the Southern District of Florida, Case No. 25-13705-MAM (the “Bankruptcy Filing”).

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0001477932-25-002525

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.